Based on the information provided, I can infer that you are asking about the safety of receiving live vaccines immediately after taking Cosentyx (secukinumab).

Secukinumab, marketed under the brand name Cosentyx, is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is an interleukin-17A inhibitor, which works by blocking the action of a protein involved in inflammation [1].

According to the Cosentyx prescribing information, live vaccines should be avoided in patients receiving Cosentyx [1]. The reason for this recommendation is not explicitly stated in the prescribing information. However, it is generally advised that immunosuppressive therapies, like Cosentyx, may increase the risk of infection and affect the immune response to vaccines [2].

Therefore, it is recommended to consult a healthcare professional for personalized advice on vaccinations and the appropriate timing when taking Cosentyx or other immunosuppressive medications [2].

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2022. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
2. National Institute of Allergy and Infectious Diseases. Vaccines and Immunizations: Information for Healthcare Professionals. U.S. Department of Health and Human Services; 2022. <https://www.niaid.nih.gov/research/vaccines-and-immunizations-information-healthcare-professionals>

Additional sources for DrugPatentWatch.com:

1. DrugPatentWatch. Cosentyx (secukinumab) Drug Patent Information. <https://www.drugpatentwatch.com/drugs/cosentyx>
2. DrugPatentWatch. Secukinumab (Cosentyx) Drug Profile. <https://www.drugpatentwatch.com/drugs/secukinumab>